Prostate-specific antigen doubling time and response to cabazitaxel in a hormone-resistant metastatic prostate cancer patient

We report a case of metastatic castration-resistant prostate cancer, who received prior treatment with docetaxel and was then given cabazitaxel as salvage therapy. The patient was monitored by prostate-specific antigen doubling time and prostate-specific antigen absolute value. The prostate-specific...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosn, Marwan, Dagher, Alain, El-Karak, Fadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Department of Journal of Biomedical Research 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585438/
https://www.ncbi.nlm.nih.gov/pubmed/26442650
http://dx.doi.org/10.7555/JBR.28.20130148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585438/
https://www.ncbi.nlm.nih.gov/pubmed/26442650
http://dx.doi.org/10.7555/JBR.28.20130148

Ejemplares similares